Boston Scientific (BSX) Tops Q2 EPS by 2c
Tweet
Share
E-mail
Get Alerts BSX Hot Sheet
Price: $44.33 -2.12%
EPS Growth %: +10.7%
Financial Fact:
Royalty expense: 20M
Today's EPS Names:
OCCI, MAYS, CRMT, More
EPS Growth %: +10.7%
Financial Fact:
Royalty expense: 20M
Today's EPS Names:
OCCI, MAYS, CRMT, More
Join SI Premium – FREE
Boston Scientific (NYSE: BSX) reported Q2 EPS of $0.44, $0.02 better than the analyst estimate of $0.42. Revenue for the quarter came in at $3.24 billion versus the consensus estimate of $3.21 billion.
GUIDANCE:
Boston Scientific sees FY2022 EPS of $1.74-$1.77, versus the consensus of $1.76.
For earnings history and earnings-related data on Boston Scientific (BSX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Goldman reinstates Estee Lauder rating, sees turnaround driving growth and margins
- Ridgepost Capital acquires Stellus Capital Management for $4B AUM
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
